BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34572143)

  • 1. Metabolomic Fingerprint of Mecp2-Deficient Mouse Cortex: Evidence for a Pronounced Multi-Facetted Metabolic Component in Rett Syndrome.
    Golubiani G; Lagani V; Solomonia R; Müller M
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rett syndrome: a neurological disorder with metabolic components.
    Kyle SM; Vashi N; Justice MJ
    Open Biol; 2018 Feb; 8(2):. PubMed ID: 29445033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome.
    Vogel Ciernia A; Yasui DH; Pride MC; Durbin-Johnson B; Noronha AB; Chang A; Knotts TA; Rutkowsky JR; Ramsey JJ; Crawley JN; LaSalle JM
    Hum Mol Genet; 2018 Dec; 27(23):4077-4093. PubMed ID: 30137367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
    Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
    Mol Autism; 2017; 8():56. PubMed ID: 29090078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain protein changes in Mecp2 mouse mutant models: Effects on disease progression of Mecp2 brain specific gene reactivation.
    Cortelazzo A; De Felice C; Guy J; Timperio AM; Zolla L; Guerranti R; Leoncini S; Signorini C; Durand T; Hayek J
    J Proteomics; 2020 Jan; 210():103537. PubMed ID: 31629059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
    Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence Phenomena and Metabolic Alteration in Mesenchymal Stromal Cells from a Mouse Model of Rett Syndrome.
    Squillaro T; Alessio N; Capasso S; Di Bernardo G; Melone MAB; Peluso G; Galderisi U
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
    Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
    Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
    Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
    PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain.
    Carli S; Chaabane L; De Rocco G; Albizzati E; Sormonta I; Calligaro S; Bonizzi P; Frasca A; Landsberger N
    Neurobiol Dis; 2023 May; 180():106083. PubMed ID: 36931532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the carnitine cycle in a mouse model of Rett syndrome.
    Mucerino S; Di Salle A; Alessio N; Margarucci S; Nicolai R; Melone MA; Galderisi U; Peluso G
    Sci Rep; 2017 Feb; 7():41824. PubMed ID: 28150739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.
    De Filippis B; Valenti D; de Bari L; De Rasmo D; Musto M; Fabbri A; Ricceri L; Fiorentini C; Laviola G; Vacca RA
    Free Radic Biol Med; 2015 Jun; 83():167-77. PubMed ID: 25708779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
    Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
    Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.